Bioleaders Corporation (142760) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.037x

Based on the latest financial reports, Bioleaders Corporation (142760) has a cash flow conversion efficiency ratio of -0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.19 Billion ≈ $-807.80K USD) by net assets (₩31.99 Billion ≈ $21.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 142760 equity to assets ratio to measure how much of total assets are equity-financed.

Bioleaders Corporation - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Bioleaders Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Bioleaders Corporation to evaluate the quality of earnings relative to operating cash generation.

Bioleaders Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioleaders Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Asuransi Jasa Tania Tbk JK:ASJT	0.043x
Nixxy, Inc. NASDAQ:NIXX	-0.096x
Oncosil Medical Ltd AU:OSL	-1.814x
Inbest Prime III Inmuebles SOCIMI S.A. MC:YINB3	N/A
WhiteSmoke Software Ltd TA:WSMK	0.008x
Imexhs Ltd AU:IME	-0.103x
Alliance Nickel Ltd AU:AXN	-0.021x
Phapros Tbk PT JK:PEHA	0.064x

Annual Cash Flow Conversion Efficiency for Bioleaders Corporation (2015–2025)

The table below shows the annual cash flow conversion efficiency of Bioleaders Corporation from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Bioleaders Corporation market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩30.57 Billion ≈ $20.71 Million	₩-5.97 Billion ≈ $-4.05 Million	-0.195x	-1352.26%
2024-12-31	₩37.31 Billion ≈ $25.28 Million	₩-501.75 Million ≈ $-340.03K	-0.013x	-107.80%
2023-12-31	₩35.79 Billion ≈ $24.26 Million	₩6.18 Billion ≈ $4.18 Million	0.173x	+118.16%
2022-12-31	₩21.69 Billion ≈ $14.70 Million	₩-20.60 Billion ≈ $-13.96 Million	-0.950x	-751.07%
2021-12-31	₩45.11 Billion ≈ $30.57 Million	₩-5.04 Billion ≈ $-3.41 Million	-0.112x	+37.04%
2020-12-31	₩30.60 Billion ≈ $20.74 Million	₩-5.43 Billion ≈ $-3.68 Million	-0.177x	-92.34%
2019-12-31	₩23.82 Billion ≈ $16.14 Million	₩-2.20 Billion ≈ $-1.49 Million	-0.092x	+75.30%
2018-12-31	₩23.50 Billion ≈ $15.92 Million	₩-8.77 Billion ≈ $-5.94 Million	-0.373x	-53.95%
2017-12-31	₩35.17 Billion ≈ $23.83 Million	₩-8.53 Billion ≈ $-5.78 Million	-0.242x	+45.00%
2016-12-31	₩17.46 Billion ≈ $11.83 Million	₩-7.70 Billion ≈ $-5.22 Million	-0.441x	+49.32%
2015-12-31	₩5.55 Billion ≈ $3.76 Million	₩-4.83 Billion ≈ $-3.27 Million	-0.870x	--

About Bioleaders Corporation

KQ:142760 Korea Biotechnology

Market Cap

$13.20 Million

₩19.48 Billion KRW

Market Cap Rank

#26305 Global

#1975 in Korea

Share Price

₩462.00

Change (1 day)

+19.38%

52-Week Range

₩363.00 - ₩1850.00

All Time High

₩24990.00